
Dr. Nicoletta Colombo breaks down KEYNOTE B96 showing Keytruda plus paclitaxel, with or without bevacizumab, improves survival in platinum-resistant ovarian cancer.
Faculty at the University of Milan-Bicocca and Director of the Gynecologic Oncology Program at the European Institute of Oncology in Milan.